12-Panel Dip Drug Screen with adulterant, Item No. PSDA-12BUP These Drugs of Abuse Tests are one-step immunoassays for the qualitative detection of multiple drugs and drug metabolites in human urine. The configurations of these Drugs of Abuse Tests consist of a combination of drug strips, including Benzodiazepine (BZO). They are used to obtain a visual, qualitative result and are intended for professional and point of care use.
Published November 25, 2015 · Recall initiated: October 20, 2015
Summary
FDA records medical device Class II recall Z-0302-2016, published November 25, 2015 and initiated October 20, 2015. Recalling firm: Ameditech Inc; Status: Terminated; Reported quantity: 960 units; Lot: 144302 150323 150661 151143 151467. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Ameditech is recalling drug abuse tests because they have shown reduced reactivity.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Ameditech Inc
- Distributor
- Worldwide Distribution - US (nationwide) and Internationally to Australia.
- Lot
- 144302 150323 150661 151143 151467
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDAImmuTest Drugs of Abuse Cup (AMT Item Number/ AMT Description): IMCA-5AB-W / "ImmuTest Drugs of Abuse CupOctober 7, 2020
- FDANoble 1 Step+ Cup (AMT Item Number/ AMT Description): NBCA-13A-B /"Noble 1 Step + Cup" THC50/COC150;October 7, 2020
- FDAFirst Check 7 Panel Drug Cup: (AMP/COC/MDMA/MET/OPI/PCP/THC); AMT Item Number 990100BOctober 7, 2020
- FDADrug Screening Component: Uncut Sheets Part Number/ Description/ LOT Number 100163/ EDI OPI (300) UncutOctober 7, 2020
- FDAEstradiol USP 99.5%, .5% Stearic Acid NF Pellets, 3 mL, one-count vials, 6 mg (NDC 69761-006-01),10 mg (NDCDecember 2, 2015
- FDA11 Panel Dip Card (OPI 2000), Item No. 11125AA2K; 11 Panel Dip Card (OPI 300) w/Adult, Item No. 11125AA TheseNovember 25, 2015
Questions about this recall
Was 12-Panel Dip Drug Screen with adulterant, Item No. PSDA-12BUP These Drugs of Abuse Tests are one-step immunoassays for the qualitative detection of multiple drugs and drug metabolites in human urine. The configurations of these Drugs of Abuse Tests consist of a combination of drug strips, including Benzodiazepine (BZO). They are used to obtain a visual, qualitative result and are intended for professional and point of care use. recalled?
Yes. FDA published recall Z-0302-2016 on November 25, 2015. Reported hazard: Ameditech is recalling drug abuse tests because they have shown reduced reactivity.
What should I do if I have this product?
Voluntary: Firm initiated · Letter